Medicare AdvantageCoverageMedium impact
MA07.032, Tumor Treating Fields
Independence Blue Cross·Oncology, Neurology, Neurosurgery·Medical Policy
Effective date
Jul 9, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.032 for Tumor Treating Fields has been reissued with an effective date of July 9, 2025. This is a policy update that may affect coverage criteria, billing requirements, or documentation standards for tumor treating field therapy.
Action Required
By July 9, 2025: Review the complete MA07.032 Tumor Treating Fields policy at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or billing procedures. Update billing workflows and staff training accordingly for any tumor treating field therapy claims.